Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus
AssigneeThe UAB Research Foundation
InventorsJohn Kappes, Xiaoyun Wu
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe UAB Research Foundation
InventorsJohn Kappes, Xiaoyun Wu
Estimating the term…
Methods and reagents for the capture of primary HIV are provided. A cell line expressing CCR5, CXCR4 and CD4 receptors binds and is infected by primary HIV. The cell line contains a marker gene sequence, the marker gene sequence expressed in near linear quantities over at least two orders of magnitude in response to HIV infection. Primary HIV is amplified to create a primary virus stock through insertion of an amplicon gene into the receptor expressing cell line. HIV amplification occurs rapidly and is operative with noninfectious HIV through amplification in the presence of an infectivity complement. The present invention is useful in determining host HIV titer, drug sensitivity, HIV amplification, gene sequencing and co-receptor utilization.
A method for determining the sensitivity of an HIV virus to an antiviral compound comprising:
An immortalized cell characterized as expressing CCR5, CXCR4, and CD4 receptors and having stably incorporated an amplicon gene operably linked to a promoter.
A method for amplifying HIV virus comprising:
Dependencies are inferred from the claim text.